Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Stress Test Feasibility in ICU Patients With Acute Kidney Injury After CRRT
ACTRN12625001227482Phase 2Recruiting
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of furosemide in acute kidney failure (AKF), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Proportion of patients who are Furosemide Stress Test responsive. Started Dec 2024; status: recruiting.
02
Drugs
furosemide
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12625001227482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001227482.